Top Clinical Trials companies in Denmark by Price to Earnings Ratio (P/E)

This ranking features the top 5 Clinical Trials companies in Denmark ranked by Price to Earnings Ratio (P/E), averaging a Price to Earnings Ratio (P/E) of -2,128.95, for January 15, 2025.

Denmark

Clinical Trials

#	Name	Price to Earnings Ratio (P/E)	Reported Date	Stock Price	Change	Country
1	Genmab A/S 1 GMAB.CO	21.39	Jan. 14, 2025	USD 216.88	1.28%	Denmark
2	Saniona AB (publ) 2 SANION.ST	-6.84	Jan. 14, 2025	USD 0.57	1.47%	Denmark
3	ViroGates A/S 3 VIRO.CO	-8.33	Jan. 14, 2025	USD 1.93	-6.19%	Denmark
4	FluoGuide A/S 4 FLUO.ST	-9.54	Jan. 14, 2025	USD 3.98	0.01%	Denmark
5	Initiator Pharma A/S 5 INIT.ST	-10,641.44	Jan. 14, 2025	USD 0.64	1.38%	Denmark

Frequently Asked Questions

Which Clinical Trials company in Denmark has the highest Price to Earnings Ratio (P/E) ?

The Clinical Trials company in Denmark with the highest Price to Earnings Ratio (P/E) is Genmab A/S (Copenhagen Stock Exchange: GMAB.CO) at 21.39.
Which Clinical Trials company in Denmark has the lowest Price to Earnings Ratio (P/E) ?

The Clinical Trials company in Denmark with the lowest Price to Earnings Ratio (P/E) is Initiator Pharma A/S (Stockholm Stock Exchange: INIT.ST) at -10,641.44.

What are the top 10 Clinical Trials companies in Denmark by Price to Earnings Ratio (P/E) ?

The top 10 Clinical Trials companies in Denmark by Price to Earnings Ratio (P/E) are Genmab A/S, Saniona AB (publ), ViroGates A/S, FluoGuide A/S and Initiator Pharma A/S.
What are the bottom 10 Clinical Trials companies in Denmark by Price to Earnings Ratio (P/E) ?

The bottom 10 Clinical Trials companies in Denmark by Price to Earnings Ratio (P/E) are Initiator Pharma A/S, FluoGuide A/S, ViroGates A/S, Saniona AB (publ) and Genmab A/S.